Clinical Trial Update: Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans [Phase 1]

View source ↗

Summary

Phase I study evaluating basic pharmacodynamic, pharmacological and toxicological effects of a newly developed Crimean-Congo hemorrhagic fever vaccine in humans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crimean-congo Hemorrhagic Fever

Drugs mentioned

• Crimean-Congo hemorrhagic fever vaccine

Snippet

Sponsor: The Scientific and Technological Research Council of Turkey | Conditions: Crimean-Congo Hemorrhagic Fever | Phase 1 | Status: COMPLETED